Work

Safety of Evobrutinib in Patients With Relapsing Multiple Sclerosis is Maintained in a Long-term Open-label Extension of a Phase II Study (4131)

Year: 2021

Type: article

Source: Neurology

DOI: 10.1212/wnl.96.15_supplement.4131

Authors: Xavier Montalban, Douglas L. Arnold, Martin S. Weber, Ivan Staikov, Karolina Piasecka-Stryczynska, Emily C. Martin, Matthew Mandel, Yulia Zima, Jamie Shaw, Fernando Dangond, Roland Grenningloh, Ying Li, Davorka Tomic, Jerry S. Wolinsky

Institutions: Vall d'Hebron Hospital Universitari, Montreal Neurological Institute and Hospital, University of Göttingen, Tokuda Hospital, Acibadem City Clinic, Poznan University of Medical Sciences, Merck KGaA, Darmstadt (Germany), Merck Healthcare KGaA, Darmstadt (Germany), The University of Texas Health Science Center at Houston

Language: English

Topic: Multiple Sclerosis Research Studies

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4389448039

FWCI: 0.167

Cites:

Cited by: 1

Related to: 10